Jiangsu Aidea Pharmaceutical Co Ltd (688488) — Cash Flow Reinvestment Rate
Jiangsu Aidea Pharmaceutical Co Ltd (688488) has a Cash Flow Reinvestment Rate of 0.51x as of September 2025, reinvesting CN¥1.81 Million (capex CN¥1.81 Million ) from operating cash flow of CN¥3.56 Million. Check 688488 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Aidea Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2020)
Historical reinvestment intensity for Jiangsu Aidea Pharmaceutical Co Ltd across 3 annual periods. Explore 688488 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2020)
Year-by-year capital reinvestment analysis for Jiangsu Aidea Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 688488 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 10.28x | CN¥577.43 Million | CN¥56.17 Million | CN¥42.43 Million | ▲ +1439.1% |
| 2019 | 0.67x | CN¥37.54 Million | CN¥56.20 Million | CN¥33.50 Million | ▼ -70.6% |
| 2016 | 2.27x | CN¥71.01 Million | CN¥31.29 Million | CN¥71.01 Million | — |